NTRK Somatic Fusions and Tumor Agnostic Treatment in Pediatric Cancers

Neurotrophic tyrosine receptor kinase (NTRK) gene rearrangements have been recently identified and developed as one of the biomarkers that have been utilized as new targets for cancer therapy. NTRK gene fusions have taken their place in individualized targeted therapy by being used as a predictive (...

Full description

Bibliographic Details
Main Authors: Emel Ünal, Sonay İncesoy Özdemir, Ayça Yağmur Şimşek
Format: Article
Language:English
Published: Rabia Yılmaz 2022-11-01
Series:Journal of Contemporary Medicine
Subjects:
Online Access:https://dergipark.org.tr/tr/download/article-file/2414338